ATE546459T1 - Verfahren zur herstellung von kristallinem ciclesonid mit definierter teilchengrösse - Google Patents

Verfahren zur herstellung von kristallinem ciclesonid mit definierter teilchengrösse

Info

Publication number
ATE546459T1
ATE546459T1 AT04723609T AT04723609T ATE546459T1 AT E546459 T1 ATE546459 T1 AT E546459T1 AT 04723609 T AT04723609 T AT 04723609T AT 04723609 T AT04723609 T AT 04723609T AT E546459 T1 ATE546459 T1 AT E546459T1
Authority
AT
Austria
Prior art keywords
particle size
producing crystalline
defined particle
crystalline ciclesonide
ciclesonide
Prior art date
Application number
AT04723609T
Other languages
English (en)
Inventor
Beate Schmidt
Klaus Eistetter
Stefan Kaupp
Ernst Sturm
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33099298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE546459(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Application granted granted Critical
Publication of ATE546459T1 publication Critical patent/ATE546459T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F21/00—Dissolving

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04723609T 2003-03-27 2004-03-26 Verfahren zur herstellung von kristallinem ciclesonid mit definierter teilchengrösse ATE546459T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03007007 2003-03-27
DE10314097 2003-03-27
PCT/EP2004/050373 WO2004085460A1 (en) 2003-03-27 2004-03-26 Process for preparing crystalline ciclesonide with defined particle size

Publications (1)

Publication Number Publication Date
ATE546459T1 true ATE546459T1 (de) 2012-03-15

Family

ID=33099298

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04723609T ATE546459T1 (de) 2003-03-27 2004-03-26 Verfahren zur herstellung von kristallinem ciclesonid mit definierter teilchengrösse

Country Status (27)

Country Link
US (1) US9422327B2 (de)
EP (1) EP1611150B1 (de)
JP (1) JP4746535B2 (de)
KR (1) KR101102709B1 (de)
AR (1) AR043579A1 (de)
AT (1) ATE546459T1 (de)
AU (1) AU2004224092B2 (de)
BR (1) BRPI0408569B1 (de)
CA (1) CA2519752C (de)
CL (1) CL2004000636A1 (de)
CY (1) CY1112970T1 (de)
DK (1) DK1611150T3 (de)
EA (1) EA011157B1 (de)
ES (1) ES2382928T3 (de)
HR (1) HRP20050917B1 (de)
IL (1) IL170746A (de)
MX (1) MXPA05010041A (de)
MY (1) MY143936A (de)
NO (1) NO331984B1 (de)
NZ (1) NZ542827A (de)
PE (1) PE20050388A1 (de)
PL (1) PL1611150T3 (de)
PT (1) PT1611150E (de)
RS (1) RS52549B (de)
SI (1) SI1611150T1 (de)
TW (1) TWI328589B (de)
WO (1) WO2004085460A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2007056181A2 (en) * 2005-11-02 2007-05-18 Sicor, Inc. Process for the preparation of ciclesonide
EP1904514A2 (de) * 2006-02-08 2008-04-02 Sicor, Inc. Kristalline formen von ciclesonide
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
WO2008062450A2 (en) * 2006-09-18 2008-05-29 Cadila Healthcare Limited Crystalline polymorphs of ciclesonide
EP2064227A2 (de) * 2006-09-19 2009-06-03 Cipla Ltd. Verfahren zur herstellung von ciclesonid und dessen kristallform
IT1397499B1 (it) * 2009-01-09 2013-01-16 Farmabios Spa Processo per la preparazione di ciclesonide
JP2011513469A (ja) * 2008-03-13 2011-04-28 ファルマビオス ソシエタ ペル アチオニ プレグナン誘導体の製造法
US20100120733A1 (en) * 2008-11-07 2010-05-13 Auspex Pharmaceuticals, Inc. Steroid modulators of glucocorticoid receptor
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
WO2014007770A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising corticosteroid and sorbitol
WO2014007781A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions
US10111957B2 (en) 2012-07-05 2018-10-30 Arven Ilac Snayi ve Ticaret A.S. Inhalation compositions comprising glucose anhydrous
RS62040B1 (sr) 2016-06-02 2021-07-30 Abbvie Inc Agonist receptora glukokortikoida i njegovi imunokonjugati
EP3658192B1 (de) 2017-12-01 2021-04-28 AbbVie Inc. Glucocorticoid-rezeptoragonist und immunkonjugate davon

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328929D0 (en) * 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds
DE68907062T2 (de) 1988-10-05 1993-10-07 Upjohn Co Feinverteiltes feste kristalline pulver durch niederschlag in einem anti-lösungsmittel.
DE407028T1 (de) 1989-05-31 1994-03-17 Fisons Plc Medikament und Inhalationsvorrichtung dafür.
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
FR2668945B1 (fr) 1990-11-12 1993-02-19 Theramex Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus.
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
CZ287877B6 (cs) 1993-04-02 2001-03-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Prednisolonové deriváty a farmaceutické prostředky s jejich obsahem
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of medicament formulations
WO1995024416A1 (de) 1994-03-09 1995-09-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue silylverbindungen und ihre verwendung
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
DE19635498A1 (de) 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB9722285D0 (en) 1997-10-23 1997-12-17 Rhone Poulenc Rorer Ltd Inhalation device
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
NZ509328A (en) * 1998-07-24 2002-11-26 Jago Res A Medicinal aerosol formulations
GB9828721D0 (en) 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
CA2376818A1 (en) * 1999-06-25 2001-01-04 Cognis Deutschland Gmbh & Co. Kg Use of nanoscale sterols and sterol esters
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
DE60142920D1 (de) 2000-11-10 2010-10-07 Nycomed Gmbh Verfahren zur herstellung von 16,17-ä(cyclohexylmethylen)bis(oxy)ü -11,21-dihydroxy-pregna-1,4-dien-3,20-dion oder ihre 21-isobutyrat durch transketalisation

Also Published As

Publication number Publication date
WO2004085460A8 (en) 2007-03-15
JP2006521332A (ja) 2006-09-21
KR101102709B1 (ko) 2012-01-05
PL1611150T3 (pl) 2012-07-31
TW200418519A (en) 2004-10-01
CL2004000636A1 (es) 2005-02-04
US20060128954A1 (en) 2006-06-15
DK1611150T3 (da) 2012-05-14
AU2004224092B2 (en) 2010-03-04
TWI328589B (en) 2010-08-11
KR20050114250A (ko) 2005-12-05
EP1611150B1 (de) 2012-02-22
JP4746535B2 (ja) 2011-08-10
EA200501391A1 (ru) 2006-06-30
BRPI0408569A (pt) 2006-03-21
PE20050388A1 (es) 2005-05-30
WO2004085460A1 (en) 2004-10-07
MXPA05010041A (es) 2005-11-17
AU2004224092A1 (en) 2004-10-07
EA011157B1 (ru) 2009-02-27
BRPI0408569B1 (pt) 2017-08-29
NZ542827A (en) 2008-02-29
HRP20050917B1 (hr) 2014-02-14
NO331984B1 (no) 2012-05-21
RS20050704A (sr) 2007-06-04
SI1611150T1 (sl) 2012-06-29
US9422327B2 (en) 2016-08-23
CY1112970T1 (el) 2016-04-13
CA2519752C (en) 2012-05-29
ES2382928T3 (es) 2012-06-14
EP1611150A1 (de) 2006-01-04
HRP20050917A2 (en) 2006-12-31
NO20054835L (no) 2005-10-19
HK1088905A1 (zh) 2006-11-17
RS52549B (sr) 2013-04-30
IL170746A (en) 2012-06-28
MY143936A (en) 2011-07-29
AR043579A1 (es) 2005-08-03
IL170746A0 (en) 2009-02-11
CA2519752A1 (en) 2004-10-07
PT1611150E (pt) 2012-05-07

Similar Documents

Publication Publication Date Title
DE60321883D1 (de) Verfahren zur Herstellung einer Vorrichtung
ATE464297T1 (de) Verbessertes verfahren zur herstellung vom rosuvastatin calcium salz
DE502004007142D1 (de) Verfahren zur herstellung einer beleuchtungsvorrichtung und beleuchtungsvorrichtung
DE602004003476D1 (de) Kondensator, halbleiterbauelement mit einem kondensator und verfahren zur herstellung derselben
ATE447942T1 (de) Verfahren zur herstellung einer gegen missbrauch gesicherten darreichungsform
ATE515500T1 (de) Verfahren zur herstellung von telmisartan
DE60324720D1 (de) Verfahren zur Herstellung dekorativer Gegenstände
DE602004020476D1 (de) Verfahren zur herstellung von thermoplastischen vulkanisaten und thermoplastischen vulkanisaten
DE60215762D1 (de) Verfahren zur Herstellung einer Mehrfachlodplatte
DE60317690D1 (de) Verfahren zur herstellung von valsartan
ATE414058T1 (de) Verfahren zur herstellung eines sulfinyl- acetamids
DE60304119D1 (de) Verfahren zur Herstellung von dünnwandigen gleichartigen Gitterstrukturen
DE502004012455D1 (de) Verfahren zur Herstellung einer Lötstoppbarriere
DE602004015834D1 (de) Verfahren zur herstellung von makeup-behältern mit
ATE308524T1 (de) Verfahren zur herstellung von aripiprazole
EP1778419A4 (de) Verfahren zur herstellung von extrusionswerkzeugen
ATE478071T1 (de) Verfahren zur herstellung neuer tiotropiumsalze
DE602005003082D1 (de) Verfahren zur Herstellung einer Vorrichtung
DE602004022134D1 (de) Verfahren zur herstellung von dinitrilen
DE50304619D1 (de) Verfahren zur herstellung eines bauteils
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
DE602004000126D1 (de) Verfahren zur Herstellung von selbststanzenden Muttern
DE502004010172D1 (de) Verfahren zur herstellung von gasturbinenrotoren mit integraler beschaufelung
ATE460414T1 (de) Verfahren zur herstellung von tiotropiumsalzen
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten